Tue.Mar 12, 2024

article thumbnail

Amid Moderna's 'transition year,' CEO Stéphane Bancel's total pay fell by about 5%

Fierce Pharma

Despite Moderna’s efforts to prove its mRNA thesis beyond COVID-19 in 2023, the post-pandemic hangover took a toll on the company. | Despite Moderna’s efforts to prove its mRNA thesis beyond COVID-19 in 2023, the post-pandemic hangover took a heavy toll on the company. In turn, much of the company’s top brass—including CEO Stéphane Bancel—saw their total compensation fall for the year.

278
278
article thumbnail

Google Cloud Releases New Clinical Generative AI Tools at HIMSS24

MedCity News

At HIMSS, Google Cloud announced new AI features designed to assist providers, payers and any other healthcare organizations seeking to make better use of their clinical data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pfizer aims Adcetris for expansion into large B-cell lymphoma after trial win

Fierce Pharma

The antibody-drug conjugate (ADC) Adcetris has given Pfizer’s oncology department its first pivotal trial win from the legacy Seagen portfolio since the $43 billion merger. | The antibody-drug conjugate Adcetris has given Pfizer’s oncology department its first pivotal trial win from the legacy Seagen portfolio since the $43 billion merger.

278
278
article thumbnail

Schizophrenia Trial Failure Ends Acadia’s Efforts to Expand Use of Its Flagship Drug

MedCity News

With pimavanserin’s Phase 3 failure in schizophrenia, Acadia Pharmaceuticals said it will no longer run clinical trials for the drug, whose lone approval is for treating psychosis from Parkinson’s disease. The FDA previously rebuffed regulatory submissions for the drug in dementia and Alzheimer’s disease.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Acadia to end Nuplazid testing after schizophrenia trial flop and years of failed expansion efforts

Fierce Pharma

Acacia Pharmaceuticals is calling it quits on future testing of Nuplazid after a string of expansion efforts have come up short. | The company will not conduct any further clinical trials of the drug, which is currently approved to treat Parkinson’s disease psychosis. The decision comes after years of failed expansion bids in other uses.

article thumbnail

Review calls for action on bias with medical devices

pharmaphorum

Healthcare systems need to address the impact of racial and ethnic biases in the design and use of medical devices, says an independent UK review.

Medical 115

More Trending

article thumbnail

Love and Solidarity: An Experience of People-Centered Care in Colombia

MedCity News

Four modest system improvements in the U.S. are assisting with valuing and activating people’s families and support networks in health care today.

article thumbnail

Older Adults’ Experience with Opioid Use, Deprescribing

Pharmaceutical Commerce

A qualitative study explores how these drugs are impacting these patients’ lives, while digging deeper into the possibility of deprescribing, with insight from primary care physicians.

article thumbnail

Pfizer’s Velsipity heading for NHS use in ulcerative colitis

pharmaphorum

Up to 25,000 patients in England with ulcerative colitis are eligible for treatment with Pfizer’s Velsipity after NICE backed use of the drug on the same day as its MHRA approval.

Patients 105
article thumbnail

ICR awarded $25m by Cancer Grand Challenges to research solid tumours in children

PharmaTimes

Globally, cancer is currently the most leading cause of death due to disease among children

Leads 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Terns scores FDA orphan designation for CML therapy

Pharmaceutical Technology

TERN-701 is a BCR-ABL tyrosine-kinase inhibitor being studied in a Phase I study, with data expected in H2 this year.

FDA 105
article thumbnail

Acadia pulls trials of pimavanserin after schizophrenia fail

pharmaphorum

Acadia Pharma has abandoned plans to develop Nuplazid for additional indications after the drug failed a phase 3 trial in schizophrenia.

Pharma 105
article thumbnail

Adopting New Manufacturing Technologies

Pharmaceutical Commerce

A sit-down with Groovy Singh, CEO of Bright Green Corporation, who describes the waves in the global supply chain the company is making after being authorized to grow cannabis, along with cannabis-related products.

article thumbnail

AAD: Sanofi showcases data on possible Dupixent successor

pharmaphorum

Sanofi says OX40L inhibitor amlitelimab could be a ‘best-in-class’ maintenance therapy for atopic dermatitis after reporting new phase 2b data

105
105
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Data integrity is the term used to describe the accuracy, consistency and reliability of data throughout its lifecycle. In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. What are three current key trends in data integrity?

article thumbnail

Software Advances Mass Customization for Cell and Gene Therapies

PharmaTech

In an interview, Fabian Gerlinghaus of Cellares outlines a paradigm change in both hardware and software, regulatory expansions, and some positive cost outcomes for the CGT field.

98
article thumbnail

As colorectal deaths rise among younger people, a screening tool could help pinpoint more patients

PharmaVoice

As colorectal deaths rise among younger people, a diagnostic could help pinpoint more patients.

article thumbnail

Inlet air conveyor optimisation in a continuous tablet coater

European Pharmaceutical Review

Coating is the oldest and last key unit operation in many tablet production processes. The function of the coating ranges from purely cosmetic improvements (brand recognition, better patient acceptance using API taste masking) to alterations of tablet release characteristics (control of the release profile and bioavailability of the API). Generally, the goal of coating is to generate a thin solid layer around the tablet core.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

NHS campaign urges over 900,000 young adults to catch up on missed MMR vaccine

PharmaTimes

Between October 2023 and March 2024, the UKHSA said that 733 cases of measles were reported in England

93
article thumbnail

Jaguar Health balances ambitions for human and animal pharmaceuticals

Pharmaceutical Technology

In an exclusive interview, Jaguar Health’s CEO discussed plans for the investigation of crofelemer in human and animal studies.

article thumbnail

A New Study Finds That Ruxolitinib Cream 1.5% Is Effective for Most Patients With HS

Pharmacy Times

The cream significantly reduced abscesses and inflammatory nodules, reaffirming its efficacy as a maintenance option for HS.

article thumbnail

Regulus cues up $100m placement on ADPKD drug data

pharmaphorum

Shares in Regulus Therapeutics leap after the company reports data with its microRNA-targeting drug in polycystic kidney disease, and files a $100m private placement.

59
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

“Food Is Medicine” Movement Takes Off

Pharmacy Times

Integrate nutrition into the health care system with a proactive approach to chronic disease management

Food 52
article thumbnail

The Strategic Use of Filtering Options in Nova Scotia Medical Directories

Scott’s Directories

In today’s healthcare industry, connecting efficiently with the right medical professionals is crucial. The physician directory by Nova Scotia is essential for healthcare professionals and organizations. By effectively using its filtering options, users can maximize the potential of this comprehensive database, which includes an extensive list of doctors in Nova Scotia.

Medical 52
article thumbnail

A Pharmacist’s Guide to Continuous Glucose Monitoring

Pharmacy Times

This guide discusses the integration of continuous glucose monitoring (CGM) technology into clinical practice, emphasizing the role of pharmacists in selecting and optimizing CGM devices for patients.

article thumbnail

How predictive analytics in healthcare can improve quality of care and lower care costs

Clarify Health

Providing high-quality care while keeping costs under control can often feel mutually exclusive. Health plans want to deliver the best possible care for their members, and that frequently takes a financial investment. But from a business perspective, health plans must find that balance between providing high-quality care at a lower cost for their members, and those that do will reap the benefits of better growth, improved member retention, and enhanced health plan profitability.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Bringing Out The Best In Medical Sales Reps With Brooke Elliott

Evolve Your Success

When Brooke Elliott got the chance to mentor medical sales reps to become the industry’s next-generation leaders, she found fulfillment in becoming a full-time coach. In her desire to help even more people, she decided to start BE Complete Coaching & Consulting. In this special episode for Women’s History Month and International Women’s Day, Brooke joins Samuel Adeyinka to share how she brings out the best in medical sales reps today.

article thumbnail

Unlock Social: 5 Ways to Accelerate Your Social Media Success

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Media 52
article thumbnail

A review of changing regulatory and analytical requirements of free amino acid monographs of the European Pharmacopoeia

Pharmaceutical Technology

Butterworth Laboratories looks at the current amino acid testing landscape since the changes in monographs introduced in 2013.

52
article thumbnail

Johnson & Johnson Submits Supplemental Biologics License Application to the FDA for Tremfya in Ulcerative Colitis Treatment

PharmExec

Submission is based on positive results from the company’s Phase III QUASAR clinical trial, in which Tremfya (guselkumab) produced positive results treating moderately to severely active ulcerative colitis.

FDA 52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A